ALLSCRIPTS HEALTHCARE SOLUTN's ticker is MDRX and the CUSIP is 01988P108. A total of 221 filers reported holding ALLSCRIPTS HEALTHCARE SOLUTN in Q4 2021. The put-call ratio across all filers is 4.36 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $966 | +8.2% | 73,490 | +3.7% | 0.01% | 0.0% |
Q2 2023 | $893 | -7.3% | 70,851 | -4.0% | 0.01% | 0.0% |
Q1 2023 | $963 | -26.1% | 73,778 | -0.2% | 0.01% | -40.0% |
Q4 2022 | $1,303 | -99.9% | 73,889 | -4.8% | 0.01% | +11.1% |
Q3 2022 | $1,182,000 | +280.1% | 77,583 | +270.0% | 0.01% | +350.0% |
Q2 2022 | $311,000 | -45.1% | 20,967 | -16.7% | 0.00% | -33.3% |
Q1 2022 | $567,000 | +27.1% | 25,158 | +4.0% | 0.00% | +50.0% |
Q4 2021 | $446,000 | +48.2% | 24,181 | +7.5% | 0.00% | 0.0% |
Q3 2021 | $301,000 | -23.8% | 22,491 | +5.5% | 0.00% | 0.0% |
Q2 2021 | $395,000 | +44.2% | 21,328 | +17.0% | 0.00% | 0.0% |
Q1 2021 | $274,000 | +27.4% | 18,234 | +22.4% | 0.00% | +100.0% |
Q4 2020 | $215,000 | -27.9% | 14,896 | -28.9% | 0.00% | -50.0% |
Q3 2018 | $298,000 | -32.3% | 20,941 | -42.9% | 0.00% | -33.3% |
Q2 2018 | $440,000 | -6.2% | 36,660 | -3.5% | 0.00% | 0.0% |
Q1 2018 | $469,000 | -44.4% | 37,997 | -34.4% | 0.00% | -50.0% |
Q4 2017 | $843,000 | +315.3% | 57,933 | +306.5% | 0.01% | +500.0% |
Q3 2017 | $203,000 | +16.0% | 14,252 | +3.9% | 0.00% | 0.0% |
Q2 2017 | $175,000 | -2.2% | 13,716 | -2.7% | 0.00% | 0.0% |
Q1 2017 | $179,000 | +24.3% | 14,100 | 0.0% | 0.00% | 0.0% |
Q4 2016 | $144,000 | -42.6% | 14,100 | -26.0% | 0.00% | -50.0% |
Q3 2016 | $251,000 | -21.3% | 19,058 | -24.2% | 0.00% | 0.0% |
Q2 2016 | $319,000 | +9.2% | 25,127 | +13.8% | 0.00% | 0.0% |
Q1 2016 | $292,000 | +14.5% | 22,086 | +33.0% | 0.00% | 0.0% |
Q4 2015 | $255,000 | -2.3% | 16,609 | -21.2% | 0.00% | 0.0% |
Q3 2015 | $261,000 | +186.8% | 21,069 | +217.6% | 0.00% | +100.0% |
Q2 2015 | $91,000 | +46.8% | 6,634 | +27.8% | 0.00% | – |
Q1 2015 | $62,000 | -6.1% | 5,190 | +0.6% | 0.00% | -100.0% |
Q4 2014 | $66,000 | -20.5% | 5,161 | -16.1% | 0.00% | 0.0% |
Q3 2014 | $83,000 | -16.2% | 6,155 | 0.0% | 0.00% | 0.0% |
Q2 2014 | $99,000 | -6.6% | 6,155 | +4.3% | 0.00% | 0.0% |
Q1 2014 | $106,000 | +15.2% | 5,902 | -1.3% | 0.00% | 0.0% |
Q4 2013 | $92,000 | -71.1% | 5,982 | -72.0% | 0.00% | -66.7% |
Q3 2013 | $318,000 | +132.1% | 21,363 | +102.4% | 0.00% | +200.0% |
Q2 2013 | $137,000 | – | 10,557 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Kent Lake Capital LLC | 925,000 | $12,154,500 | 4.67% |
EVR Research LP | 1,289,037 | $16,937,946 | 4.48% |
Tamarack Advisers, LP | 435,000 | $5,715,900 | 3.70% |
KESTREL INVESTMENT MANAGEMENT CORP | 263,900 | $3,468 | 2.19% |
Tamarack Advisers, LP | 200,000 | $2,628,000 | 1.70% |
Numerai GP LLC | 274,319 | $3,604,552 | 1.20% |
Smith, Graham & Co., Investment Advisors, LP | 525,915 | $6,910,523 | 0.86% |
PEREGRINE CAPITAL MANAGEMENT LLC | 585,254 | $7,690,238 | 0.23% |
WESTFIELD CAPITAL MANAGEMENT CO LP | 2,401,754 | $31,559,048 | 0.22% |
FULLER & THALER ASSET MANAGEMENT, INC. | 2,543,242 | $33,418,194 | 0.19% |